LCM
DRNA

Laurion Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Laurion Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,045
Closed -$343K – 786
2020
Q3 		$343K Buy
+19,045
New +$343K ﹤0.01% 455
2018
Q2 		– Sell
-11,754
Closed -$112K – 1396
2018
Q1 		$112K Buy
+11,754
New +$112K ﹤0.01% 983